Read about the latest news and developments at IDT Biologika, including the company’s growth, innovations and community involvement.
You can also access our entire archive of press releases and follow our activity on social media.
CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine more info
Prime Minister hails exemplary success story more info
The pharmaceuticals company intends to use this takeover to continue expanding its herd-specific vaccine business more info
IDT Biologika receives three Life Science Leader’s more info
RT @CEPIvaccines: Since first being identified in 2012, #MERS has claimed nearly 800 lives out of 2,229 confirmed cases. We are now workin… more info
RT @CEPIvaccines: Today, we announced a partnership with German company @IDTBiologika to develop a #MERS vaccine. Germany's Federal Ministe… more info
RT @BMBF_Bund: @idtbiologika -Geschäftsführer Andreas Kastenbauer unterzeichnete heute den Vertrag mit der CEPI. Die Forschenden aus Dessau… more info